Daniel K. Spiegelman - 06 Jun 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Reporting relationship: Director
Issuer ticker: MYGN
Reported as of: 06 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jun 2024, 16:53:29 UTC
Prior SEC filing: 04 Jun 2024
Next SEC filing: 13 Jun 2024
Source filing: View source filing
Reporting owner signature: By: Justin Hunter For: Daniel K. Spiegelman

Key filing fact

Daniel K. Spiegelman filed Form 4 for MYRIAD GENETICS INC (MYGN) on 07 Jun 2024.

Key facts

This page summarizes Daniel K. Spiegelman's Form 4 filing for MYRIAD GENETICS INC (MYGN).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Jun 2024, 16:53.

Change

Previous filing in this sequence was filed on 04 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 32,917
Date: 06 Jun 2024
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Daniel K. Spiegelman is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

SEC remarks

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a director of the Company, effective June 6, 2024, and therefore is no longer subject to Section 16 reporting